Technical Analysis for BTX - Brooklyn ImmunoTherapeutics, Inc.

Grade Last Price % Change Price Change
C 21.6 -7.81% -1.83
BTX closed down 7.81 percent on Friday, May 14, 2021, on 67 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Down
Historical BTX trend table...

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Older End-of-Day Signals for BTX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 1 day ago
60 Minute Opening Range Breakdown 1 day ago
Down 5% 1 day ago
Down 3% 1 day ago
Down 2 % 1 day ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Brooklyn ImmunoTherapeutics LLC develops cytokine based immune therapies to treat cancer and related diseases. The company develops IRX-2, a therapeutic containing cytokine components, which restore and activate multiple immune cell types, including T cells, dendritic cells and natural killer cells. The company also engages in bio-pharmaceutical research. Brooklyn ImmunoTherapeutics LLC was formerly known as IRX Therapeutics, Inc and changed its name to Brooklyn ImmunoTherapeutics LLC in November, 2018. The company was founded in 1994 and is based in New York, New York.
Classification

Sector: Consumer Cyclical
Industry: Broadcasting - TV
Keywords: Cancer Clinical Medicine Immunology Immune System Immunotherapy Related Diseases T Cell Dendritic Cell Natural Killer Cell

Is BTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 80.67
52 Week Low 0.94
Average Volume 6,565,618
200-Day Moving Average 5.63
50-Day Moving Average 14.95
20-Day Moving Average 30.70
10-Day Moving Average 38.98
Average True Range 9.34
ADX 58.17
+DI 31.54
-DI 18.41
Chandelier Exit (Long, 3 ATRs ) 52.65
Chandelier Exit (Short, 3 ATRs ) 34.03
Upper Bollinger Band 65.59
Lower Bollinger Band -4.20
Percent B (%b) 0.37
BandWidth 227.36
MACD Line 4.49
MACD Signal Line 7.57
MACD Histogram -3.0715
Fundamentals Value
Market Cap 64 Million
Num Shares 2.96 Million
EPS -0.05
Price-to-Earnings (P/E) Ratio -423.53
Price-to-Sales 0.66
Price-to-Book 13.25
PEG Ratio -0.69
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 28.31
Resistance 3 (R3) 28.90 27.27 27.19
Resistance 2 (R2) 27.27 25.56 26.97 26.81
Resistance 1 (R1) 24.43 24.50 23.62 23.84 26.44
Pivot Point 22.80 22.80 22.39 22.50 22.80
Support 1 (S1) 19.96 21.09 19.15 19.37 16.76
Support 2 (S2) 18.33 20.03 18.03 16.39
Support 3 (S3) 15.49 18.33 16.01
Support 4 (S4) 14.90